Genoil annual stock-based compensation
2020
2021
2022
2023
2024
2025
Genoil Stock-Based Compensation Growth & History (GNOLF)
Genoil's stock-based compensation was $54,000 for fiscal 2025.
View full Genoil company overviewGenoil annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $54,000 | −$1.3M | −96.01% |
| 2024 | 2024-12-31 | $1.4M | −$1.7M | −56.26% |
| 2023 | 2023-12-31 | $3.1M | $1.9M | +149.14% |
| 2022 | 2022-12-31 | $1.2M | $525,199 | +73.23% |
| 2021 | 2021-12-31 | $717,163 | −$2.8M | −79.41% |
| 2020 | 2020-12-31 | $3.5M | — | — |
Genoil quarterly stock-based compensation
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $37,000 | −$1.3M | −97.27% |
| Q3 2025 | 2025-09-30 | $3,000 | — | — |
| Q2 2025 | 2025-06-30 | $11,000 | — | — |
| Q1 2025 | 2025-03-31 | $3,000 | — | — |
| Q4 2024 | 2024-12-31 | $1.4M | — | — |
Genoil stock-based compensation trends
Over the last five fiscal years, Genoil's stock-based compensation decreased from $3.5M to $54,000, a change of −$3.4M. The latest reported quarter, Q4 2025, shows $37,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genoil source filings ↗